ICCC Projected Dividend Yield

ImmuCell Corp. ( NASDAQ : ICCC )

ImmuCell is an animal health company. Co. focuses on creating products that improve the health and productivity of dairy and beef cattle. The First Defense® product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. The target disease, calf scours (bovine enteritis), causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death. The First Defense® product line is an orally delivered scours preventive product on the market for calves with claims against E. coli, coronavirus and rotavirus. Co.'s Beyond Vaccination® marketing campaign focuses on providing antibodies without vaccination.

20 YEAR PERFORMANCE RESULTS